Christopher Mirabelli Net Worth & Insider Trades

Christopher Mirabelli - Director, Leap Therapeutics, Inc

As of September 2, 2022

What is Christopher Mirabelli's Net Worth?

The current estimated net worth of Leap Therapeutics, Inc's Director, Christopher Mirabelli, is estimated to be about $41.53M . Christopher Mirabelli owns about 4,458,693 units of Leap Therapeutics, Inc common stock. In the last 5 years at Leap Therapeutics, Inc, Christopher Mirabelli has sold an estimated value of $0 worth.

What is Christopher Mirabelli's Past Insider Trading?

Christopher Mirabelli's largest purchase order was 1,057,769 units , worth over $6.44M on November 16, 2017. In total, Christopher Mirabelli has made about 14 transactions over 5 years of their time at Leap Therapeutics, Inc. Christopher Mirabelli usually trades in February and January, with the busiest year in 2019 and 2021. The most recent transaction was a purchase order of 571,428 units , worth over $1M on February 5, 2019.

Christopher Mirabelli

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Christopher Mirabelli's' Mailing Address?

  • Mailing address is 55 Cambridge Parkway Suite 301 Cambridge MA 02142 MA

What are Leap Therapeutics, Inc's Past Insider Trades?

Leap Therapeutics, Inc's most recent insider trade came on September 28, 2021 by Beigene Ltd who bought 2,543,800 units worth $7.25M . In the last 4 years, insiders at Leap Therapeutics, Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in January, with the busiest year in 2020. The most active traders at the company are Augustine Lawlor, Chief Operating Officer,  Christopher Mirabelli, Director,  and Douglas E Onsi, CEOCFO,Pres.,GC,Treas.,&Sec. .

LEAP THERAPEUTICS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1